<DOC>
	<DOCNO>NCT00690105</DOCNO>
	<brief_summary>Patients facial atopic eczema poor response topical corticosteroid apply either Protopic Fluticasone ointment twice day 3 week . They could continue 3 week day need change ointment .</brief_summary>
	<brief_title>Protopic Ointment Adult Atopic Eczema Face</brief_title>
	<detailed_description>Treatments apply twice daily lesion face ( except eyelid ) clearance , maximum 3 week , case uncleared residual lesion , daily 3 week . In event flare-up treatment resume twice day end study .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Moderate severe AD ( Rajka &amp; Langeland score ) lesion head neck define 'red face ' 'facial eczema ' : erythema affect least 10 % surface 'face ' ( head , neck , chest , nape neck ) , due longterm AD At least two flareups 'facial ' eczema 12 month prior inclusion , investigator 's opinion , conventional treatment prove ineffective poorly tolerate Female patient childbearing age : effective mean contraception throughout period study four week follow end study Informed consent Therapeutic washout atopic dermatitis treatment Genetic epidermal barrier defect , Netherton 's syndrome , suffer erythroderma Seborrheic dermatitis contact dermatitis affect 'face ' , facial erythema nonatopic origin Clinical infection due VZV virus ( varicella , zona ) , HSV12 viruses ( herpes ) , verruca vulgaris molluscum contagiosum Superinfected eczema Known hypersensitivity macrolides excipient tacrolimus 0.1 % ointment Known hypersensitivity one agent contain fluticasone 0.005 % ointment preparation Ulcerated lesion , whatever type Moderate severe acne rosacea Patients participate time another clinical study participate another clinical study within 28 day prior inclusion study Any type substance abuse ( include drug alcohol ) mental disorder/psychological state , investigator 's opinion , might interfere patient 's followup Serologicallyproven HIV positivity</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Dermatologic Agents</keyword>
	<keyword>Topical Drug Administration</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Calcineurin</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>Face</keyword>
</DOC>